Dredd2Kad asks: "I'd really like Slashdot's opinion on this. I recently secured an MP3 distribution deal with an indie record label, and negotiations with other indie labels and artists are in the works. The music will be distributed through my internet radio station's website. As you know, if you can sell music in a format such as MP3 you eliminate the costs of packaging, shipping, handling. You do have to contend with bandwidth charges though. Most indie labels and artists seem happy to pass along the savings to customers and stimulate sales. What I have built is simple and functional. We are trying to add value to the MP3 albums we sell by including quality artwork that can be printed onto CD labels and jewel case inserts (so you aren't just getting a 'bunch of files'). What would make you want to buy music in this way? What types things would turn you away? What are the positives and negatives of selling music in this manner? Do you think this is a viable alternative to someone who doesn't want to pay $10 or $15 for a physical CD? Does the format the music is in or on have an impact on how serious you take it?"

An anonymous reader wrote: "CNN.com is running an interesting story on the heels of a Forrester Research report concerning the shift of high tech jobs from the U.S. to places like China, India, and Russia for cheaper labor and got me thinking about the nature of the current downtrend in programmer demand in the U.S (as opposed to the "morality" of such a shift). While I'm sure the causes for this downtrend are variable, the more important question in my mind is this -- Is software guru Bruce Eckel correct in saying that the current downturn represents a temporary blip in the business cycle as jobs are shifted from large and medium companies to smaller companies, or are Andy Hunt and Dave Thomas correct in recognizing this as a new reality. Personally I tend to agree with Hunt and Thomas's view (which is not completely opposed to Bruce's opinion, btw) and I also agree with their viewpoint that protectionist policies like H1B quotas and tariffs won't work to change anything for the better. So what do you think? Is this just another business cycle or is this a New World Order in IT?"

DentistsScareMe! asks: "I'll admit it: I've got yellow-stained teeth, and it bugs the hell out of me. I've seen ads (infomercials) over the past few years, but knew them to be mostly hoax products and have steered clear. But now I've noticed the more major (and reputable) pharmaceutical companies jumping into the act, offering their own products. They're moderately expensive ($30-$50), but I'd be willing to foot the large sum _if_ I knew how well they worked. Their ads claim clinical proof, but what exactly does that mean? Did a researcher test the drug on a sample of people to measure effectiveness? Does use of the phrase 'clinically proven' require anything like FDA approval? Has anyone out there used any such product, or know someone who has? Care to comment on how well it has worked?"

One of the beautiful things about Open Source is that the barriers to entry are next to non-existent, and the adage "have compiler, will travel" embodies this fact well enough. However, as projects grow in size, they will soon face financial stumbling blocks, not to mention a need for increased visibility. How does one best market an Open Source project? What can Joe (or Joni) Coder do to increase their project's financial stability? Have the financially minded people of the Free Software community thought out the possibility of an Open Investment firm? Read on for Slashdot readers who are asking these exact questions!